Senores Pharmaceuticals Limited (NSE:SENORES)

Senores Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Senores Pharmaceuticals had annual revenue of 6.33B INR with 58.85% growth. Senores Pharmaceuticals had revenue of 1.75B in the quarter ending March 31, 2026, with 53.39% growth.

• Revenue: 6.33B
• Revenue Growth: +58.85%
• P/S Ratio: 9.58
• Revenue / Employee: n/a
• Employees: 194
• Market Cap: 60.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.33B	2.34B	58.85%
Mar 31, 2025	3.98B	1.84B	85.65%
Mar 31, 2024	2.15B	1.79B	507.07%
Mar 31, 2023	353.37M	211.67M	149.38%
Mar 31, 2022	141.70M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error